The European Medicines Agency's Committee for Medicinal Products for Human Use found that Leqembi’s benefits do not outweigh the risks of severe side effects associated with the treatment. https://hubs.li/Q02J4tY70 #regulatory #pharma #alzheimers #biospace
BioSpace
Internet News
West Des Moines, Iowa 113,872 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Head of Insights
Updates
-
Follow along as we keep you up-to-date on the latest pharma and biotech layoffs. Today, our Layoff Tracker 2024 features updates from Anokion, GlycoMimetics, Relay Therapeutics and more. https://hubs.li/Q02J4g2T0 #layoffs #lifesciences #pharma #biotech #biospace
Biopharma Layoff Tracker 2024: Anokion, GlycoMimetics, Relay and More Cut Staff
biospace.com
-
In the latest update of our FDA Decision Tracker, we cover the regulator's approval of SUN PHARMA's severe alopecia areata treatment. https://hubs.li/Q02J4f-40 #pharma #regulatory #biospace
FDA Greenlights Sun Pharma’s Severe Alopecia Areata Treatment
biospace.com
-
Despite their initial kicking and screaming, drugmakers seem confident the Inflation Reduction Act’s Medicare Drug Price Negotiation Program will not greatly impact their bottom lines. https://hubs.li/Q02J3Qq_0 #pharma #regulatory #finance #biospace
Big Pharma Appears to Be Unfazed by IRA Drug Price Negotiations
biospace.com
-
Bristol Myers Squibb on Friday reported strong second-quarter results, led by the blood thinner Eliquis and cancer therapy Opdivo, as it looks to cut $1.5 billion in costs by 2025. https://hubs.li/Q02J3Chg0 #pharma #finance #biospace
BMS Gets Q2 Beat, Raises Full-Year Guidance as Cost-Cutting Initiative Continues
biospace.com
-
Encouraged by the potential of the weight-loss candidates acquired from Carmot Therapeutics, Inc., Roche will speed up the development of its obesity programs, seeking to differentiate itself in the market. https://hubs.li/Q02J3s_f0 #pharma #obesity #biospace
Roche to Accelerate Development of Obesity Assets from $2.7B Carmot Buy
biospace.com
-
The FDA's Oncologic Drugs Advisory Committee on Thursday strongly supported changing clinical trials for non-small cell lung cancer drugs given in the perioperative setting, pointing out the need for a more nuanced approached to treatments before and after surgery. https://hubs.li/Q02J3Dt30 #regulatory #pharma #oncology #biospace
FDA Adcomm Calls for Changes in Perioperative Lung Cancer Trials
biospace.com
-
argenx's FcRn inhibitor Vyvgart grew 17% quarter-over-quarter, reigniting confidence it will hit its ambitious goals despite a string of clinical setbacks in recent months. https://hubs.li/Q02J3p250 #pharma #biospace
Argenx’s Strong Q2 Sales Reinvigorate Clinical Plans for Vyvgart
biospace.com
-
We’re working on a story about whether scientist roles should require a Ph.D. regardless of experience. Please vote in the poll, and feel free to share your thoughts in the comments. Note: Comments may be used in the article, and we'd especially love to get input from hiring managers. Also, if you’re willing to talk to the writer, you can message Angela Gabriel here on LinkedIn or email her at angela.gabriel@biospace.com, and she may reach out to you.
This content isn’t available here
Access this content and more in the LinkedIn app
-
While Humira sales were impacted by cheaper biosimilars, AbbVie reported in its second-quarter earnings results Thursday that revenues jumped nearly 45% for Skyrizi and almost 56% for Rinvoq year over year, respectively. https://hubs.li/Q02HZxDr0 #finance #biospace
Despite Near 30% Drop in Humira Sales, AbbVie Beats Wall Street’s Q2 Revenue Expectations
biospace.com